Scarinci Hollenbeck, LLC, LLCScarinci Hollenbeck, LLC, LLC

Firm Insights

Supreme Court Decision on Genetic Patents Shifts Biotech IP Landscape

Author: Scarinci Hollenbeck, LLC

Date: July 3, 2013

Key Contacts
Back

The U.S. Supreme Court recently issued a mixed decision on the patentability of human genes.

The justices concluded that a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but that cDNA (complimentary DNA) is patent eligible because it is not naturally occurring.

human genes

The patents at issue in Association For Molecular Pathology. et al. v. Myriad Genetics, Inc., et al. relate to Myriad’s discovery of the precise location and sequence of the BRCA1 and BRCA2 genes. Mutations in these genes can dramatically increase an individual’s risk of developing breast and ovarian cancer. Myriad had used its DNA patents to claim exclusive rights to isolate an individual’s BRCA1 and BRCA2 genes for testing.

The Court found that Myriad’s DNA claim falls within the law of nature exception to patent eligibility. As explained in the opinion, “Myriad did not create or alter either the genetic information encoded in the BCRA1 and BCRA2 genes or the genetic structure of the DNA. It found an important and useful gene, but groundbreaking, innovative, or even brilliant discovery does not by itself satisfy the §101 inquiry.”

As a natural product, that human DNA cannot be patented was a result obvious to many.  While initially celebrated as a victory for civil liberties, scientific freedom, and patients, the implications of the decision are not clear.

The Court also concluded that cDNA is not a “product of nature” and, thus, it is patent eligible. “Its creation results in an exons-only molecule, which is not naturally occurring. Its order of the exons may be dictated by nature, but the lab technician unquestionably creates something new when introns are removed from a DNA sequence to make cDNA.” the Court held.

While the decision at first glance seems to draw a simple, bright line between DNA (not patentable) and cDNA (patent eligible), it may just be the initial stage of the next patent battles, for cDNA is the workhorse in molecular research.  However, cDNA is, in a nutshell, a laboratory “copy” (that has the same genetic information as a copied gene) that does not require much effort to create.

As for how the decision will impact patents currently pending before the U.S. Patent and Trademark Office, the agency has already issued preliminary guidance. It states that Myriad significantly changes the Office’s examination policy regarding nucleic acid-related technology. Going forward, the USPTO provides the following guidance to its patent examiners:

As of today, naturally occurring nucleic acids are not patent eligible merely because they have been isolated. Examiners should now reject product claims drawn solely to naturally occurring nucleic acids or fragments thereof, whether isolated or not, as being ineligible subject matter under 35 U.S.C. § 101. Claims clearly limited to non-naturally-occurring nucleic acids, such as a cDNA or a nucleic acid in which the order of the naturally occurring nucleotides has been altered (e.g., a man-made variant sequence), remain eligible. Other claims, including method claims, that involve naturally occurring nucleic acids may give rise to eligibility issues and should be examined under the existing guidance in MPEP 2106, Patent Subject Matter Eligibility.

To be sure, by invalidating the DNA patents, the Court did lift a barrier to innovation, but whether scientific and medical progress is facilitated by the decision remains to be seen, as trade secrets protection of discoveries will likely be emphasized in the future.

If you have any questions about this case or would like to discuss the legal issues involved, please contact me, Kenneth Oh, or the Scarinci Hollenbeck attorney with whom you work.

No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.

Scarinci Hollenbeck, LLC, LLC
Related Posts
See all
Fort Monmouth Redevelopment Agreements: Key Contractual Considerations for Developers and Investors post image
Fort Monmouth Redevelopment Agreements: Key Contractual Considerations for Developers and Investors

A Fort Monmouth redevelopment agreement imposes obligations beyond a traditional property purchase, including construction deadlines, financial commitments, permitted uses, and restrictions on future transfers. Fort Monmouth’s ongoing redevelopment presents significant opportunities for real estate developers, investors, and businesses seeking to establish or expand their presence in Monmouth County. However, acquiring and developing property at the […]

Author: Donald M. Pepe

Link to post with title - "Fort Monmouth Redevelopment Agreements: Key Contractual Considerations for Developers and Investors"
BESS Safety and Emergency Response: Legal Issues for Developers and Property Owners post image
BESS Safety and Emergency Response: Legal Issues for Developers and Property Owners

As battery energy storage system (BESS) projects move from planning to construction, developers and property owners must address an issue that extends well beyond zoning approvals and interconnection agreements: what happens when something goes wrong? To avoid unforeseen liability, developers should address fire code compliance, emergency response planning, contractual risk allocation, and environmental liability before […]

Author: Nicholas Wall

Link to post with title - "BESS Safety and Emergency Response: Legal Issues for Developers and Property Owners"
Rule 26 Expert Discovery: When an Expert Witness Uses AI, Is It Discoverable? post image
Rule 26 Expert Discovery: When an Expert Witness Uses AI, Is It Discoverable?

Case law following the 2010 amendments to Federal Rule of Civil Procedure 26 offers guidance on how courts are likely to address whether an expert witness’s AI records are subject to discovery. Key Takeaways Rule 26 Expert Discovery After the 2010 Amendments This article addresses the question courts and lawyers have faced in recent cases: […]

Author: Chris Seelinger

Link to post with title - "Rule 26 Expert Discovery: When an Expert Witness Uses AI, Is It Discoverable?"
How Expert Witness AI Use Ends Up in Discovery post image
How Expert Witness AI Use Ends Up in Discovery

“Show how 3M is 0% at fault.” The absurd tale of how a 350-page ChatGPT history for 3M’s expert witness was produced during a deposition is more likely than you think. It’s an inevitable trend, and an unsettled question for federal courts as experts make generative AI part of their workflow. Key Takeaways Expert Witness […]

Author: Chris Seelinger

Link to post with title - "How Expert Witness AI Use Ends Up in Discovery"
The Screenshot Problem: Why Nothing Is Really Private Anymore post image
The Screenshot Problem: Why Nothing Is Really Private Anymore

Screenshots have changed the risks of electronic communications. The screenshot problem is that messages intended for one person or a small group can be copied, forwarded, preserved, and ultimately presented to opposing counsel, regulators, journalists, customers, or a jury. Businesses should recognize that a truly private digital conversation is increasingly unreliable and ensure their policies, […]

Author: Sean M. Pena

Link to post with title - "The Screenshot Problem: Why Nothing Is Really Private Anymore"
BESS Project Agreements: Allocating Risk Among Developers, EPC Contractors, and Equipment Suppliers post image
BESS Project Agreements: Allocating Risk Among Developers, EPC Contractors, and Equipment Suppliers

Developers, engineering, procurement, and construction (EPC) contractors, and equipment suppliers each play a critical role in completing a BESS project. However, when equipment costs rise, deliveries are delayed, or regulations change, determining who bears the financial consequences can become contentious. Well-drafted project agreements are essential to sound risk allocation. Key Takeaways This article is Part […]

Author: Nicholas Wall

Link to post with title - "BESS Project Agreements: Allocating Risk Among Developers, EPC Contractors, and Equipment Suppliers"

No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.

Sign up to get the latest from our attorneys!
Explore What Matters Most to You.

Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.

Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.

Let`s get in touch!

* The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form. By providing a telephone number and submitting this form you are consenting to be contacted by SMS text message. Message & data rates may apply. Message frequency may vary. You can reply STOP to opt-out of further messaging.
“If you would like to submit a file, please email it directly to info@sh-law.com.

Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!